<p>The video above is from Tuesday's <em>MarketFoolery</em> podcast, featuring host Chris Hill and analysts Joe Magyer and Bill Mann. In this segment, the guys look at <strong>Johnson & Johnson</strong>'s <span class="ticker" data-id="204142"><ticker exchange="NYSE" symbol="JNJ">(NYSE: JNJ)</ticker></span> latest earnings report, which turned out better than expected thanks to prescription drug sales and JNJ's medical device division. They also discuss why the company's growth opportunity in China is stronger than people may think.</p>
<p><p><span style="color: #222222; font-family: Arial, sans-serif;"><span style="font-size: 14px;">If you're looking for some additional ideas or insights on your quest for high-yielding stocks, The Motley Fool has compiled a special free report outlining our top nine <em>dependable</em> dividend-paying companies. It's called "<a href="http://www.fool.com/fool/free-report/18/sa-9dividend-display-136071.aspx?aid=4313&source=isaeditxt0900001">Secure Your Future With 9 Rock-Solid Dividend Stocks</a>," and you can access your complimentary copy today at no cost. Simply <a href="http://www.fool.com/fool/free-report/18/sa-9dividend-display-136071.aspx?aid=4313&source=isaeditxt0900001">click here now</a> to get started and discover the winners we've selected.<br /></span></span></p></p>
Full-time host of the Motley Fool Money radio show, MarketFoolery podcast, and other things. Part-time connoisseur of movies, basketball & fine bourbon.